Qiagen NV (QGEN) Sees Unusually-High Trading Volume
Qiagen NV (NASDAQ:QGEN) saw an uptick in trading volume on Friday . 943,591 shares changed hands during trading, an increase of 6% from the previous session’s volume of 893,382 shares.The stock last traded at $26.60 and had previously closed at $26.55.
A number of research firms have weighed in on QGEN. TheStreet upgraded Qiagen NV from a “hold” rating to a “buy” rating in a report on Friday, July 29th. JPMorgan Chase & Co. reiterated a “hold” rating on shares of Qiagen NV in a report on Friday, July 29th. HSBC upgraded Qiagen NV from a “hold” rating to a “buy” rating in a report on Monday, August 1st. Mizuho upped their target price on Qiagen NV from $22.00 to $25.00 and gave the stock a “neutral” rating in a report on Monday, August 1st. Finally, Zacks Investment Research upgraded Qiagen NV from a “hold” rating to a “buy” rating and set a $30.00 target price on the stock in a report on Wednesday, August 3rd. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $25.73.
The stock’s 50-day moving average is $25.16 and its 200-day moving average is $22.74. The firm has a market cap of $6.24 billion and a price-to-earnings ratio of 53.36.
Qiagen NV (NASDAQ:QGEN) last announced its quarterly earnings data on Thursday, July 28th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.23 by $0.01. During the same period in the previous year, the business earned $0.26 EPS. The firm earned $334.40 million during the quarter, compared to the consensus estimate of $326.73 million. The firm’s revenue for the quarter was up 4.7% on a year-over-year basis. Equities analysts anticipate that Qiagen NV will post $1.09 earnings per share for the current fiscal year.
A hedge fund recently raised its stake in Qiagen NV stock. Bank of Montreal Can boosted its stake in Qiagen NV (NASDAQ:QGEN) by 18.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 439,239 shares of the company’s stock after buying an additional 67,343 shares during the period. Bank of Montreal Can owned 0.19% of Qiagen NV worth $12,145,000 as of its most recent SEC filing.
QIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.